Neighborhood Diabetes

Established in 1956, Lantheus Medical Imaging is one of the leading manufacturers of diagnostic imaging equipment and related products in the United States. Its products include xenon gas, injectable suspensions, generators, dispensing pins, injections and technetium kits. The company provides Cardiolite, which is an injection kit that is used in myocardial perfusion imaging application. It additionally offers DEFINITY, which is used in suboptimal echocardiograms. The company also supplies a variety of products under the VIALMIX, TechneLite, Neurolite and INTELLPIN brands. It provides sales, marketing, distribution, technical support, and research and development services. Lantheus Medical Imaging maintains offices in Puerto Rico, Canada and Australia.

Seven Bridges, now Velsera, is a leading biomedical data company based in Cambridge, MA, specializing in software and data analytics for public and private healthcare research. Their end-to-end bioinformatic solutions provide access to datasets, analytic workflows, cloud-computing infrastructure, and scientific support to expedite the journey from raw experimental data to new treatments and diagnostics. With a focus on collaboration, discovery, data compute, and security compliance, Seven Bridges empowers researchers in biopharma, government, and academia to leverage genomic and clinical data for innovative research and development. Their platform offers immediate access to extensive public datasets and bioinformatics tools, facilitating streamlined clinical trial research and accelerating the speed to market for new healthcare solutions.Generated from the website

Hemophilia is an inherited bleeding disorder in which the blood does not clot normally because of a missing or dysfunctional clotting protein. Clotting proteins, also called clotting factors, work with other blood components such as platelets, von Willebrand factor, and other proteins to form a blood clot. When any of these components is absent or low, increased bleeding can result. If clotting factor VIII (8) or factor IX (9) are affected, this bleeding disorder is called hemophilia.